Circulation-Cardiovascular Quality and Outcomes

Papers
(The H4-Index of Circulation-Cardiovascular Quality and Outcomes is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China506
Recommendations for Reporting Machine Learning Analyses in Clinical Research105
Race, Racism, and Cardiovascular Health: Applying a Social Determinants of Health Framework to Racial/Ethnic Disparities in Cardiovascular Disease105
2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to 70
Importance of Housing and Cardiovascular Health and Well-Being: A Scientific Statement From the American Heart Association69
The Groundwater of Racial and Ethnic Disparities Research65
Rapid Diet Assessment Screening Tools for Cardiovascular Disease Risk Reduction Across Healthcare Settings: A Scientific Statement From the American Heart Association58
Randomized Pragmatic Trial of Stroke Transitional Care52
Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care Patients50
Understanding How Cardiac Arrest Complicates the Analysis of Clinical Trials of Cardiogenic Shock46
Obesity Prevalence and Risks Among Chinese Adults: Findings From the China PEACE Million Persons Project, 2014–201845
Survival in Patients With Suspected Myocardial Infarction With Nonobstructive Coronary Arteries: A Comprehensive Systematic Review and Meta-Analysis From the MINOCA Global Collaboration44
Cardiovascular and Cerebrovascular Disease Mortality in Asian American Subgroups43
Characteristics and Outcomes of In-Hospital Cardiac Arrest Events During the COVID-19 Pandemic42
Changes in the United States Adult Heart Allocation Policy42
American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines41
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure39
Harnessing Mobile Health Technology for Secondary Cardiovascular Disease Prevention in Older Adults: A Scientific Statement From the American Heart Association38
Utilization and Availability of Advanced Imaging in Patients With Acute Ischemic Stroke37
Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis35
Working Agenda for Black Mothers34
Code Blue During the COVID-19 Pandemic34
Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: A Health Economic Analysis34
Psychological Outcomes and Interventions for Individuals With Congenital Heart Disease: A Scientific Statement From the American Heart Association33
Contemporary Trends in Hospital Admissions and Outcomes in Patients With Critical Limb Ischemia33
Use of Mobile Health Applications in Low-Income Populations33
Digital Health Intervention in Acute Myocardial Infarction32
Advancing Value-Based Models for Heart Failure32
External Validations of Cardiovascular Clinical Prediction Models: A Large-Scale Review of the Literature32
Supervised Exercise Therapy for Symptomatic Peripheral Artery Disease Among Medicare Beneficiaries Between 2017 and 2018: Participation Rates and Outcomes31
Cardiovascular Health Score and Lifetime Risk of Cardiovascular Disease30
0.077993154525757